HPE NICE TA552 handbook

TA552 TECHNOLOGY APPRAISAL GUIDANCE Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia NICE has checked the use of its content in this product. NICE is independent of any company or product advertised.